Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-055483
Filing Date
2026-05-13
Accepted
2026-05-13 08:51:47
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0289555-10q_onconetix.htm   iXBRL 10-Q 1299684
2 CERTIFICATION ea028955501ex31-1.htm EX-31.1 11170
3 CERTIFICATION ea028955501ex31-2.htm EX-31.2 11233
4 CERTIFICATION ea028955501ex32-1.htm EX-32.1 4325
5 CERTIFICATION ea028955501ex32-2.htm EX-32.2 4295
  Complete submission text file 0001213900-26-055483.txt   7022262

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE onco-20260331.xsd EX-101.SCH 63547
7 XBRL CALCULATION FILE onco-20260331_cal.xml EX-101.CAL 46312
8 XBRL DEFINITION FILE onco-20260331_def.xml EX-101.DEF 307293
9 XBRL LABEL FILE onco-20260331_lab.xml EX-101.LAB 545250
10 XBRL PRESENTATION FILE onco-20260331_pre.xml EX-101.PRE 322073
77 EXTRACTED XBRL INSTANCE DOCUMENT ea0289555-10q_onconetix_htm.xml XML 844501
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 26971144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)